SARS-CoV-2 Infection
Showing 1 - 25 of 247
COVID-19, SARS-CoV-2 Infection Trial in United States (AZD9838, Licensed mRNA vaccine)
Not yet recruiting
- COVID-19
- SARS-CoV-2 Infection
- AZD9838
- Licensed mRNA vaccine
-
Long Beach, California
- +4 more
Nov 24, 2023
SARS-CoV-2 Infection, COVID-19 Trial in Australia, New Zealand (BNT162b2, Placebo, Seasonal Inactivated Influenza Vaccine)
Completed
- SARS-CoV-2 Infection
- COVID-19
- BNT162b2
- +2 more
-
Brookvale, New South Wales, Australia
- +25 more
Nov 22, 2023
SARS-CoV-2 Infection, COVID-19 Trial in Australia, New Zealand (BNT162b2, Placebo, Seasonal Inactivated Influenza Vaccine)
Completed
- SARS-CoV-2 Infection
- COVID-19
- BNT162b2
- +2 more
-
Brookvale, New South Wales, Australia
- +25 more
Nov 13, 2023
SARS-CoV-2 Infection Trial in Dengfeng, Zhengzhou (COVID-19 mRNA Vaccine (ZSVG-02-O), COVID-19 Vaccine (Vero Cell) ,Inactivated)
Recruiting
- SARS-CoV-2 Infection
- COVID-19 mRNA Vaccine (ZSVG-02-O)
- COVID-19 Vaccine (Vero Cell) ,Inactivated
-
Dengfeng, Henan, China
- +1 more
Nov 6, 2023
SARS-CoV-2 Infection Trial in Hangzhou (Placebo, COVID-19 Vaccine (Vero Cell) ,Inactivated, COVID-19 mRNA Vaccine (ZSVG-02-O) 10
Recruiting
- SARS-CoV-2 Infection
- Placebo
- +4 more
-
Hangzhou, Zhejiang, ChinaShulan (Hangzhou) Hospital
Nov 7, 2023
SARS-CoV-2 Infection, COVID-19, Coronavirus Trial in Marseille, Nîmes (eBAM Cov Testing)
Not yet recruiting
- SARS-CoV-2 Infection
- +2 more
- eBAM Cov Testing
-
Marseille, France
- +1 more
Oct 23, 2023
SARS-CoV-2 Infection Trial in Baltimore (B/HPIV3/S-6P)
Recruiting
- SARS-CoV-2 Infection
- B/HPIV3/S-6P
-
Baltimore, MarylandJohns Hopkins Bloomberg School of Public Health
Aug 30, 2023
SARS-CoV-2 Infection, COVID-19 Trial in United States (BNT162b2 (Omi XBB.1.5))
Not yet recruiting
- SARS-CoV-2 Infection
- COVID-19
- BNT162b2 (Omi XBB.1.5)
-
Dublin, California
- +14 more
Aug 10, 2023
SARS-CoV-2 Infection, Varicella, Measles Trial in Shanghai (Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine,
Not yet recruiting
- SARS-CoV-2 Infection
- +4 more
- Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine
- +2 more
-
Shanghai, Shanghai, ChinaShanghai Municipal Center for Disease Control and Prevention
Jul 17, 2023
COVID-19, SARS-CoV-2 Infection Trial (SCTV01E-2, SCTV01E)
Not yet recruiting
- COVID-19
- SARS-CoV-2 Infection
- SCTV01E-2
- SCTV01E
- (no location specified)
Jul 4, 2023
SARS-CoV-2 Infection, COVID-19 Trial in Derby (Remdesivir)
Not yet recruiting
- SARS-CoV-2 Infection
- COVID-19
-
Derby, United KingdomUniversity of Derby
Jun 21, 2023
SARS-CoV-2 Infection Trial in Shinagawa-ku (S-217622, Placebo)
Recruiting
- SARS-CoV-2 Infection
- S-217622
- Placebo
-
Shinagawa-ku, Higashioi, JapanTokyo Shinagawa Hospital Social Medical Corporation Association
Jun 13, 2023
Worsening by Voice and Respiratory Pattern Characteristics
Not yet recruiting
- Sars-CoV-2 Infection
- COVID-19
- COVOICE application use - initial
- COVOICE application use - follow-up
-
Saint-Mandé, FranceHôpital d'Instruction des Armées Bégin
Jun 6, 2023
The ACDC Study Assessing Cognitive Deterioration in COVID-19
Recruiting
- SARS-CoV-2 Infection
- +2 more
- Magnetic Resonance Imaging
-
Aberdeen, Grampian, United KingdomAberdeen Royal Infirmary
May 10, 2023
Sars-CoV-2 Infection Trial in South Africa (Alveavax-v1.2, Janssen Ad26.COV2.S)
Completed
- Sars-CoV-2 Infection
- Alveavax-v1.2
- Janssen Ad26.COV2.S
-
Bloemfontein, Free State, South Africa
- +7 more
May 2, 2023
Infectious Viral Load: a Prospective Observational Study
Recruiting
- SARS-CoV-2 Infection
- +3 more
- No intervention
-
Geneva, SwitzerlandGeneva University Hospital
Mar 20, 2023
Zinc Deficiency, Sars-CoV-2 Infection Trial in Barcelona (Zinc Acetate)
Completed
- Zinc Deficiency
- Sars-CoV-2 Infection
- Zinc Acetate
-
Barcelona, SpainHospital del Mar
Mar 18, 2023
Sars-CoV-2 Infection Trial in Negrar (Nasal and mouth swab)
Active, not recruiting
- Sars-CoV-2 Infection
- Nasal and mouth swab
-
Negrar, Verona, ItalyIRCCS Sacro Cuore Don Calabria hospital
Mar 14, 2023
SARS-CoV-2 Infection Trial in Beijing (HH-120 nasal spray 1, HH-120 nasal spray 2, Placebo Comparator 1)
Completed
- SARS-CoV-2 Infection
- HH-120 nasal spray 1
- +3 more
-
Beijing, Beijing, ChinaBeijing Ditan Hospital,Capital Medical University
Mar 1, 2023
COVID-19, SARS-CoV-2 Infection Trial in Beijing (HH-120 Nasal Spray)
Completed
- COVID-19
- SARS-CoV-2 Infection
- HH-120 Nasal Spray
-
Beijing, Beijing, ChinaBeijing Ditan Hospital,Capital Medical University
Feb 26, 2023
Security Efficacy COVID-19 Vaccination
Completed
- Autoimmune State
- SARS-CoV-2 Infection
- Blood sampling
-
Milan, ItalyIstituto Auxologico Italiano IRCCS
Feb 23, 2023
Project STARFISH - PRJ0002679
Not yet recruiting
- SARS-CoV-2 Infection
- +3 more
- The Applied Biosystems™ TaqPath™ COVID-19, Flu A, Flu B, RSV Select Panel
- (no location specified)
Feb 14, 2023
SARS-CoV-2 Infection Trial in Mexico (AVX-COVID/12, ChAdOx-1-S[recombinant])
Recruiting
- SARS-CoV-2 Infection
- AVX-COVID/12
- ChAdOx-1-S[recombinant]
-
Mexico City, Cdmx, Mexico
- +13 more
Feb 3, 2023
SARS-CoV-2 Infection, Staff Attitude, Anxiety Trial in Hangzhou (Online-based self-help psychological intervention, Provide
Recruiting
- SARS-CoV-2 Infection
- +3 more
- Online-based self-help psychological intervention
- Provide online mental health knowledge
-
Hangzhou, Zhejiang, ChinaThe Second Affiliated Hospital of Zhejiang University anesthesio
Feb 2, 2023